in Newswire Published on November 15, 2019

Two Women File Class Action After Study Exposes Ineffectiveness of Preterm Birth Drug Makena [UPDATE]

by Erin Shaak

Last Updated on May 16, 2025

Faughnan et al. v. AMAG, Inc.

Filed: November 12, 2019 § 3:19-cv-01394

A lawsuit filed against Makena manufacturer AMAG, Inc. claims the “exorbitantly-priced” preterm birth medication is “no more effective than a placebo.”

Defendant(s)

AMAG, Inc.

Law(s)

State(s)

New York

May 16, 2025 – Makena Class Action Lawsuit Settlement Reached for $7.5M

Case Spotlight

Video Game Addiction Lawsuits

How Do I Join a Class Action Lawsuit?

ClassAction.org Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

Last Updated on May 16, 2025 — 9:22 AM

Erin Shaak

erin@classaction.org

Erin works primarily on ClassAction.org’s newswire, reporting on cases as they happen.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.